{"id":"https://genegraph.clinicalgenome.org/r/b7e64fa5-10c8-4d9a-a8f2-c7df8e958f05v1.1","type":"EvidenceStrengthAssertion","dc:description":"GJB2 was first reported in relation to autosomal recessive nonsyndromic hearing loss (DFNB1) in 1997 (Kelsell et al., PMID: 9139825). 8 variants (missense, nonsense, frameshift, and canonical splice site) that have been reported in 6 probands in 4 publications (PMIDs: 9139825, 9482292, 9529365, 16380907) are included in this curation. Variants in GJB2 are found in up to 50% of patients with autosomal recessive nonsyndromic hearing loss (PMID: 16380907). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by experimental evidence. Expression studies in the human cochlea, mouse models with wildtype GJB2 rescuing hearing loss and abnormal inner ear morphology, and in vitro dye transfer and electrical coupling assays demonstrating significant differences between functionally impaired variants and wildtype GJB2 all support this gene-disease relationship (PMIDs: 9507396, 12176036, 15241677, 21876744, 25801282). In summary, there is definitive evidence supporting the relationship between GJB2 and autosomal recessive nonsyndromic hearing loss. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Hearing Loss Gene Curation Expert Panel on March 2, 2017. As of September 24, 2024, this record underwent administrative updates to update the SOP version (SOP Version 10.1). No new evidence has been reviewed or added.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/b7e64fa5-10c8-4d9a-a8f2-c7df8e958f05","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9af2d792-a1fc-4b96-ae23-ee7a31dd2f99","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9af2d792-a1fc-4b96-ae23-ee7a31dd2f99_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2024-09-24T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/9af2d792-a1fc-4b96-ae23-ee7a31dd2f99_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2024-09-24T13:30:12.872Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9af2d792-a1fc-4b96-ae23-ee7a31dd2f99_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b38d54a-320e-40a9-a0d9-c157a8ffe6f1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b38d54a-320e-40a9-a0d9-c157a8ffe6f1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16380907","rdfs:label":"1 of 17 subjects","allele":{"id":"https://genegraph.clinicalgenome.org/r/517e6937-a2de-4a2d-a10d-41116d982f00","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004004.6(GJB2):c.167del (p.Leu56ArgfsTer26)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA172217"}},"detectionMethod":"SSCP, denaturing gradient gel electrophoresis, denaturing high-performance liquid chromatography, allele-specific PCR, restriction-enzyme digestion, DNA sequencing.","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/a5b05684-d4a7-4650-8df6-6463d25db7af_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16380907","allele":{"id":"https://genegraph.clinicalgenome.org/r/517e6937-a2de-4a2d-a10d-41116d982f00"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/a5b05684-d4a7-4650-8df6-6463d25db7af","type":"EvidenceLine","dc:description":"Downgrading by 0.5 for homozygosity and another 0.5 for unclear consanguinity, remaining conservative with scoring.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5b05684-d4a7-4650-8df6-6463d25db7af_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3b91b33c-0a91-44c2-9fe3-9d055c7aac5d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b91b33c-0a91-44c2-9fe3-9d055c7aac5d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16380907","rdfs:label":"1 of 16 subjects","allele":[{"id":"https://genegraph.clinicalgenome.org/r/da88d3ba-31f6-4fbb-abc4-c222848c9516","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004004.6(GJB2):c.-23+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA172205"}},{"id":"https://genegraph.clinicalgenome.org/r/69ca0bdd-fea8-444d-8570-15eac42f2dc0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004004.6(GJB2):c.35del (p.Gly12ValfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA127023"}}],"detectionMethod":"SSCP, denaturing gradient gel electrophoresis, denaturing high-performance liquid chromatography, allele-specific PCR, restriction-enzyme digestion, DNA sequencing.","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0c973bd7-6519-45dd-bd13-cd69fc7b0999_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16380907","allele":{"id":"https://genegraph.clinicalgenome.org/r/da88d3ba-31f6-4fbb-abc4-c222848c9516"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/19f76e62-248c-4db5-a54f-3ca65e000332_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16380907","allele":{"id":"https://genegraph.clinicalgenome.org/r/69ca0bdd-fea8-444d-8570-15eac42f2dc0"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/0c973bd7-6519-45dd-bd13-cd69fc7b0999","type":"EvidenceLine","dc:description":"Functional data confirms predicted effect.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c973bd7-6519-45dd-bd13-cd69fc7b0999_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0c973bd7-6519-45dd-bd13-cd69fc7b0999_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"No transcript from the allele carrying ivs1(+1) G→A was detectable (PMID: 11935342).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/19f76e62-248c-4db5-a54f-3ca65e000332","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19f76e62-248c-4db5-a54f-3ca65e000332_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/19f76e62-248c-4db5-a54f-3ca65e000332_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"c.35del GJB2 is not expressed in HeLa cells and only 1.5% of those cells were positive for propidium iodide (PI) dye transfer (PMID: 33466560).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/ac852a3d-1ec8-4df9-97c5-ad911c65940e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac852a3d-1ec8-4df9-97c5-ad911c65940e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9482292","rdfs:label":"Estivill Proband (One of many)","allele":{"id":"https://genegraph.clinicalgenome.org/r/69ca0bdd-fea8-444d-8570-15eac42f2dc0"},"firstTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/7bbb9707-a625-4524-b9c3-60c4f2f64faa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9482292","allele":{"id":"https://genegraph.clinicalgenome.org/r/69ca0bdd-fea8-444d-8570-15eac42f2dc0"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/7bbb9707-a625-4524-b9c3-60c4f2f64faa","type":"EvidenceLine","dc:description":"0.5 points were deducted for homozygosity, but consanguinity was uncertain, and given that this variant is reported in an abundance of cases, it was left at 2.5 points total.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bbb9707-a625-4524-b9c3-60c4f2f64faa_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/7a906386-3b15-4dd4-a578-0afe40b4a030_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a906386-3b15-4dd4-a578-0afe40b4a030","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9529365","rdfs:label":"Kelley Proband","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a93fc824-9e0a-46ff-9d43-7424849df457","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004004.6(GJB2):c.101T>C (p.Met34Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA172206"}},{"id":"https://genegraph.clinicalgenome.org/r/1d302067-140a-4451-920f-71e5582e5ce4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004004.6(GJB2):c.283G>A (p.Val95Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA172220"}}],"detectionMethod":"SSCP, denaturing gradient gel electrophoresis, denaturing high-performance liquid chromatography, allele-specific PCR, restriction-enzyme digestion, DNA sequencing.","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/351600a2-e1d3-4f54-b928-691f62584042_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9529365","allele":{"id":"https://genegraph.clinicalgenome.org/r/a93fc824-9e0a-46ff-9d43-7424849df457"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/45c748a3-ba52-4f7e-8215-f9be34bb916d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9529365","allele":{"id":"https://genegraph.clinicalgenome.org/r/1d302067-140a-4451-920f-71e5582e5ce4"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/351600a2-e1d3-4f54-b928-691f62584042","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/351600a2-e1d3-4f54-b928-691f62584042_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/351600a2-e1d3-4f54-b928-691f62584042_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"No dye transfer was observed between clusters of cells expressing the M34T variant (PMID: 12176036).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/45c748a3-ba52-4f7e-8215-f9be34bb916d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/45c748a3-ba52-4f7e-8215-f9be34bb916d_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/45c748a3-ba52-4f7e-8215-f9be34bb916d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"No intercellular dye transfer (PMID: 16217030).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/3e7852b9-deda-4f00-ab6b-ee4de1bc6206_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e7852b9-deda-4f00-ab6b-ee4de1bc6206","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9139825","rdfs:label":"Kelsell Proband 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/22af4176-f516-4684-9f83-521b0baa9af0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004004.6(GJB2):c.71G>A (p.Trp24Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA172240"}},"firstTestingMethod":"Linkage analysis","secondTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/5c6d5246-fee4-4497-a5ca-f61e07b3465f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9139825","allele":{"id":"https://genegraph.clinicalgenome.org/r/22af4176-f516-4684-9f83-521b0baa9af0"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/5c6d5246-fee4-4497-a5ca-f61e07b3465f","type":"EvidenceLine","dc:description":"Reducing score by 0.5 points for homozygosity and 0.5 points for consanguinity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c6d5246-fee4-4497-a5ca-f61e07b3465f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/171ae138-b46b-470e-9bb3-ef607a20b0e1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/171ae138-b46b-470e-9bb3-ef607a20b0e1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9139825","rdfs:label":"Kelsell Proband 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/7d5e7fef-b80a-49ef-b04f-3d5bea66fff5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004004.6(GJB2):c.231G>A (p.Trp77Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA341437"}},"firstTestingMethod":"Linkage analysis","secondTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/27bc0067-1343-4fa4-95f7-132e41815f76_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9139825","allele":{"id":"https://genegraph.clinicalgenome.org/r/7d5e7fef-b80a-49ef-b04f-3d5bea66fff5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/27bc0067-1343-4fa4-95f7-132e41815f76","type":"EvidenceLine","dc:description":"Score is reduced by 0.5 points for homozygosity and 0.5 points for consanguinity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/27bc0067-1343-4fa4-95f7-132e41815f76_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/9af2d792-a1fc-4b96-ae23-ee7a31dd2f99_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9af2d792-a1fc-4b96-ae23-ee7a31dd2f99_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79189aa9-786b-4bfc-a9f9-af5a4e67299c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bcbc2e9-b684-48b3-98ab-dd3c7bd47124","type":"Finding","dc:description":"Immunohistochemical analysis of human connexin 26 expression in the stria vascularis, basement membrane, limbus, and the spiral prominence of the cochlea is consistent with the hypothesis that Cx26 mutations can be involved in the molecular pathology of these forms of hereditary deafness.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9507396","rdfs:label":"Cochlear Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9af2d792-a1fc-4b96-ae23-ee7a31dd2f99_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24de1bc5-746c-4706-89a9-d21d62fc4437","type":"EvidenceLine","dc:description":"Multiple variants are shown to alter function and this type of assay is replicated across multiple studies.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24a19e9f-e1ff-441e-bca8-f81a5a27dab2","type":"FunctionalAlteration","dc:description":"Wild-type Cx26 formed functional channels with junctional conductance that was 100-fold higher than background levels recorded in antisense-oligonucleotide-injected control pairs. In contrast, the junctional conductances of the R143W, V153I and L214P variants were equal to or less than background levels (P>0.05, Student’s unpaired t-test), establishing the inabilities of these mutants to form functional intercellular channels. T8M and N206S mutants did electrically couple cells, though their voltage gating properties were different from wild-type Cx26 channels. However, both functional mutants had macroscopic conductance significantly lower than wild-type GJB2 (P<0.05, compared with GJB2).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15241677","rdfs:label":"Electrical Coupling Assays"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/603e9693-5faf-4265-b5d3-91ae521e7e76","type":"EvidenceLine","dc:description":"Dye transfer assays are well replicated across multiple studies for multiple variants in GJB2.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3e9f4eb-e542-4a62-83a9-894ee4153823","type":"FunctionalAlteration","dc:description":"No dye transfer was observed between clusters of cells expressing the variants 35delG (n=30), G12V (n=32), S19T (n=30), and M34T (n=51), whereas variants L90P and R127H showed a very low incidence of dye transfer (13.5%, n=81, and 11.8%, n=102, respectively) compared to wtCx26.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12176036","rdfs:label":"Dye Transfer"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9af2d792-a1fc-4b96-ae23-ee7a31dd2f99_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/249cbcca-f11d-4fd1-b04a-3de3cbf3a368","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7690a429-2fc4-41d6-908b-f9d26eaaa254","type":"Finding","dc:description":"Gap junction coupling is restored. These results suggest that restoration of normal connexin levels by gene delivery via recombinant AAV could be a way to rescue hearing function in DFNB1 mouse models and might, in future, lead to the development of therapeutic interventions in humans, particularly in children.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21876744","rdfs:label":"BAAV mediated GJB2 gene transfer","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ea2bcd0f-c2ad-4630-bf3c-28393c2591eb","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6937fcb2-c302-47d0-8276-f0723feb951f","type":"Finding","dc:description":"Histological examinations revealed proper formation of the tunnel of Corti and preservation of inner and outer hair cells, as well as supporting cells. These rescued phenotypes were more apparent at the basal turn than at the apical turn. Morphological differences between turns may have resulted from differential access to the perilymph through the round window membrane. AAV transduction lasted over 6 months. Non-rescued cochleae showed unchanged ABR thresholds and collapsed organs of Corti and degenerated hair cells. Spiral ganglion neuron degeneration was examined by light microscopy. In non-rescued cochleae, both apical and middle turns showed a mild-to-moderate loss of spiral ganglion neurons, whereas a marked reduction in spiral ganglion neurons was observed at the basal turn. Spiral ganglion neurons at the middle and basal turns were apparently better preserved than those in non-rescued cochleae. Quantitative analysis of the height of the pillar cell and the number of spiral ganglion neurons was performed. The height of the pillar cells of the basal turn in rescued cochleae, which failed to reach full maturation as compared with controls, was significantly increased as compared with that of non-rescued cochleae. Quantitative analysis showed that spiral ganglion neuron degeneration progressed from base to apex in Gjb2-deficient mice. Gjb2 transfer resulted in a significant increase in the density of neurons at the middle and basal turns. Thus, prevention of both hair cell and spiral ganglion neuron degeneration well explains the preservation of the ABR responses in Gjb2 transfected cochleae.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25801282","rdfs:label":"Hearing loss rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":8997,"specifiedBy":"GeneValidityCriteria10","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/wJQxMwSZgAw","type":"GeneValidityProposition","disease":"obo:MONDO_0019497","gene":"hgnc:4284","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9af2d792-a1fc-4b96-ae23-ee7a31dd2f99-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}